FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like Feds Appeared at Perrigo's HQ With Search Warrants Yesterday May 2, 2017 Palatin Forges $40.5M+ Deal With Korea's Kwangdong Pharma November 20, 2017 New Study Indicates DNA Plays Role in Gender Identity March 18, 2018